CYDY
CYTODYN INC by CytoDyn Inc. (CYDY)
$32
About CYTODYN INC by CytoDyn Inc. (CYDY)
CytoDyn, Inc. is a clinical-stage biotechnology company, which focuses on the clinical development of innovative treatments for multiple therapeutic indications based on its product candidate, leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5. Its pipeline includes Leronlimab Clinical Development Pipeline and Long-Acting CCR5 Inhibitor Development Pipeline. The company was founded by Allen D. Allen on May 2, 2002 and is headquartered in Vancouver, WA.
Details
Daily high
$0.32
Daily low
$0.30
Price at open
$0.31
52 Week High
$0.49
52 Week Low
$0.11
Market cap
384.3M
Dividend yield
0.00%
Volume
1.4M
Avg. volume
2.0M
P/E ratio
-16.68
CYTODYN INC by CytoDyn Inc. News
Details
Daily high
$0.32
Daily low
$0.30
Price at open
$0.31
52 Week High
$0.49
52 Week Low
$0.11
Market cap
384.3M
Dividend yield
0.00%
Volume
1.4M
Avg. volume
2.0M
P/E ratio
-16.68